Not sure if I am reading it correctly, but it looks to me as though $5.7m of the op cash receipts came from "other receivables". These receivables were indicated in the previous AR to be items purchased for a contract and then resold. The associated cashflow showed $6.047m being paid for these assets under investing cashflows (ie they were on-sold at a loss).
Surprised the receipts don't come under investing cashflow too if that is the case, but I guess these things can move around sometimes.
Anyway, good luck to holders with the Agathis buy-out. Lot of money to spend if they are really cleaning up a mess. We will always be left wondering if the original Nexbis sellers are now somewhere in Agathis getting it back for a similar sum (with contracts now established and derisked).
- Forums
- ASX - By Stock
- Ann: Half Yearly Report and Accounts
Not sure if I am reading it correctly, but it looks to me as...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NBS (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.9¢ |
Change
0.000(0.00%) |
Mkt cap ! n/a |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online